AP NEWS
ADVERTISEMENT
PRESS RELEASE: Paid content from Globe Newswire
Press release content from Globe Newswire. The AP news staff was not involved in its creation.

THC Therapeutics, Inc. Independently Tested, Patented Sanitizing Cannabis Dryer More Relevant ...

December 22, 2020 GMT

The dHydronator’s SanitiZen® technology has been proven to reduce the microbial load level of cannabis from failing laboratory testing and brings the contaminants down to passing levels.

THC Therapeutics, Inc. (THCT), a forward-thinking publicly traded technology company whose mission statement is “Better Health through the Science of Nature,” today announced that due to the raised awareness of contagions and contaminants because of the global pandemic, its patented technology is more relevant than ever.

LAS VEGAS, Dec. 22, 2020 (GLOBE NEWSWIRE) -- A significant percentage of commercial marijuana flower, trim and shake batches tested by independent laboratories for microbials fail to meet state regulations. A growing problem for legal cannabis over the past several years, cannabis-containing mold and yeast has supplanted banned pesticides, which were found in some of the tested cannabis in 2019, as a dispensary shopper’s main cause for concern.

ADVERTISEMENT

THC Therapeutics has developed a sanitizing herb dryer, The dHydronator®, with multiple design, function, and usage patent protections. This innovative, laboratory-proven product is specifically designed for drying and sanitizing freshly harvested Cannabis, herbs, teas, etc. The dHydronator® can reduce the moisture content of Cannabis to approximately 10% in only 10-14 hours. Traditional Cannabis drying times can take up to two weeks.

To see test results, click here.

With our built-in SanitiZen® technology, we are able to reduce the microbial load from failing cannabis and bring the contaminants down to passing levels. The device can kill surface Aspergillus, E. coli, Penicillium, Alternaria, Cladosporium, yeasts, botrytis, mites, and more. We’ve subjected the dHydronator to 9 independent tests over two laboratories and 6 strains of cannabis to confirm the findings. The dHydronator is capable of sanitizing and drying cannabis without harming the integrity of the plant.

Brandon Romanek, our Founder and Chairman, stated, “I could not be more elated that the US Patent and Trademark Office, a short time ago, accepted all 20 of the claims for the dHydronator®. While we expected patent protection, we did not expect to receive such broad protection on our intellectual property. Many in the Cannabis industry liked our technology; however, they expressed serious doubts that we would receive any type of patent protection—much less the protection afforded by all 20 of our claims.”

ADVERTISEMENT

Parker Mitchell, our Chief Executive Officer, stated, “One of the main reasons I became CEO of THC Therapeutics, after doing my due diligence, was that I was astounded to see what the application of THCT’s intellectual property is capable of. The patent on the dHydronator® is one of a kind. We are exploring financing and capital raising options so we that we can bring this revolutionary technology to market.

For more information on THCT, visit: https://thct.io/.

About THC Therapeutics

THC Therapeutics, Inc. (THCT) is focused on developing their patented dHydronator®, a sanitizing herb dryer. The main function of the dHydronator® is to greatly accelerate the drying time of cannabis while sanitizing it. The dHydronator® can be used to dry a variety of herbs; it has been specifically tested for use with cannabis, and it can reduce the drying time for cannabis from 10-14 days to less than 14 hours. The Company may also focus some of its future operations on participation in cannabis-testing lab facilities and developing personal wellness centers. The Company is seeking partnerships in the Cannabis & Health/Wellness industries in the United States & Canada.

For more information, visit THCT.io

Forward-Looking Statements Disclosure

Any statements that are not historical facts contained in this press release are “forward-looking statements” as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA), which statements may be identified by words such as “expects,” “plans,” “projects,” “will,” “may,” “anticipates,” “believes,” “should,” “intends,” “estimates,” and other words of similar meaning. Such forward-looking statements are based on current expectations, involve known and unknown risks, a reliance on third parties for information, transactions that may be cancelled, and other factors that may cause our actual results, performance or achievements, or developments in our industry, to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from anticipated results include risks and uncertainties related to the fluctuation of global economic conditions or economic conditions with respect to the cannabis industry, the performance of management, actions of government regulators and vendors, our ability to obtain financing, competition, general economic conditions and other factors that are detailed in our filings with the Securities and Exchange Commission (“SEC”). We intend that all forward-looking statements be subject to the safe-harbor provisions of the PSLRA.

PR & Media Contact:

Phone number 1-833-420-THCT

info@THCT.io